Matches in Wikidata for { <http://www.wikidata.org/entity/Q63571407> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q63571407 description "clinical trial" @default.
- Q63571407 description "ensayu clínicu" @default.
- Q63571407 description "klinisch onderzoek" @default.
- Q63571407 description "клінічне випробування" @default.
- Q63571407 name "A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors" @default.
- Q63571407 type Item @default.
- Q63571407 label "A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors" @default.
- Q63571407 prefLabel "A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors" @default.
- Q63571407 P1132 Q63571407-EF9373F3-63D1-4AF6-A79B-EFC81A238A91 @default.
- Q63571407 P1476 Q63571407-4BAA7D5B-4A4B-4091-B7FD-31EA9E59591D @default.
- Q63571407 P17 Q63571407-0433105A-5698-4411-A21B-DB6066A145FF @default.
- Q63571407 P17 Q63571407-054AD864-16B2-409C-AF29-DF60ED9C22AA @default.
- Q63571407 P17 Q63571407-068E2279-C7B1-40D4-AAC7-584820F9F1D6 @default.
- Q63571407 P17 Q63571407-4E5F0926-5ED4-40EE-8616-AC738C093033 @default.
- Q63571407 P17 Q63571407-62C27043-E45D-4E0F-A1CC-922E5AF3B950 @default.
- Q63571407 P17 Q63571407-A76A8F11-D16D-43ED-89D7-20E0B41C277C @default.
- Q63571407 P17 Q63571407-EC1F553B-0688-48F2-84AC-E27919668452 @default.
- Q63571407 P2899 Q63571407-56B212DD-E23C-4AA9-8C8D-BCFEEF3FF97D @default.
- Q63571407 P3098 Q63571407-1CEF74DB-A1FA-4D2E-92A2-82A6D62804CB @default.
- Q63571407 P31 Q63571407-B59A8C40-374A-487D-B2D0-94789E1FC56D @default.
- Q63571407 P4844 Q63571407-535B150A-7486-4180-A7DA-E182E99BAAB6 @default.
- Q63571407 P580 Q63571407-D75F617C-F29D-4E73-B096-25CE1553FC3D @default.
- Q63571407 P582 Q63571407-D4117DE3-C8CE-412E-BA37-C55FC5265EB8 @default.
- Q63571407 P6099 Q63571407-26A920FA-4B58-4999-A3AB-D2F342AC33C3 @default.
- Q63571407 P6153 Q63571407-3C34C513-D384-4C6B-8597-D7825FAC2C95 @default.
- Q63571407 P6153 Q63571407-66D5E54C-9E0D-46FF-8C31-A68A136516CC @default.
- Q63571407 P6153 Q63571407-8BA460CF-5679-4DB5-949E-54426D2D0BB9 @default.
- Q63571407 P6153 Q63571407-A42BEEAA-B58F-4D69-AE9C-B98123BBFEDD @default.
- Q63571407 P6153 Q63571407-BDC9E9BC-CF34-41A9-83FD-35463D9AB8D4 @default.
- Q63571407 P6153 Q63571407-DD1BB1BB-0EE3-41B6-890A-3D8D4C6D2457 @default.
- Q63571407 P8363 Q63571407-80BBF629-E740-4512-BCCD-3354E2D73EC9 @default.
- Q63571407 P859 Q63571407-4E64C958-86CD-42B5-A700-C8CA4B3CF96F @default.
- Q63571407 P1132 "+149" @default.
- Q63571407 P1476 "An Open-Label, Multicenter, Dose-Escalation Phase I Study to Evaluate the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688, A Novel T-cell Bispecific Antibody That Targets the Human Carcinoembryonic Antigen (CEA) on Tumor Cells and CD3 on T Cells, Administered Intravenously in Patients With Locally Advanced and/or Metastatic CEA(+) Solid Tumors" @default.
- Q63571407 P17 Q142 @default.
- Q63571407 P17 Q16 @default.
- Q63571407 P17 Q29 @default.
- Q63571407 P17 Q30 @default.
- Q63571407 P17 Q35 @default.
- Q63571407 P17 Q38 @default.
- Q63571407 P17 Q55 @default.
- Q63571407 P2899 "+18" @default.
- Q63571407 P3098 "NCT02324257" @default.
- Q63571407 P31 Q30612 @default.
- Q63571407 P4844 Q389496 @default.
- Q63571407 P580 "2014-12-30T00:00:00Z" @default.
- Q63571407 P582 "2019-06-26T00:00:00Z" @default.
- Q63571407 P6099 Q5452194 @default.
- Q63571407 P6153 Q1468161 @default.
- Q63571407 P6153 Q2415975 @default.
- Q63571407 P6153 Q2536586 @default.
- Q63571407 P6153 Q30270369 @default.
- Q63571407 P6153 Q41506 @default.
- Q63571407 P6153 Q6806451 @default.
- Q63571407 P8363 Q78089383 @default.
- Q63571407 P859 Q212646 @default.